免责声明 本公司具有中国证监会核准的期货交易咨询业务资格。本内容的观点和信息仅供国泰君安期货的专业投资者参考。本内容难以设 置访问权限,若给您造成不便,敬请谅解。若您并非国泰君安期货客户中的专业投资者,请勿阅读、订阅或接收任何相关信息。 本内容不构成具体业务的推介,亦不应被视为任何投资、法律、会计或税务建议,且本公司不会因接收人收到本内容而视其为客 户。本内容的信息来源于公开资料,本公司对这些信息的准确性、完整性及未来变更的可能性不作任何保证。请您根据自身的风 险承受能力作出投资决定并自主承担投资风险,不应凭借本内容进行具体操作,本公司不对因使用本内容而造成的损失承担任何 责任。除非另有说明,本公司拥有本内容的版权和/或其他相关知识产权。未经本公司事先书面许可，任何单位或个人不得以任 何方式复制、转载、引用、刊登、发表、发行、修改、翻译此报告的全部或部分内容。 本周模型对下周IH、IF、IC、IM基差的运动方向判断分别为:走强、走强、走强、 走虫。 近期预测结论 I H IF 1. 00% 1. 00% 真实基差变动 真实基差变动 预测基差变动 预测基差变动 0. 75% 0. 75% 0. 50% 0. 5 ...

Core Viewpoint - The average brokerage recommendation (ABR) for Onto Innovation (ONTO) is 1.88, indicating a consensus between Strong Buy and Buy, based on recommendations from eight brokerage firms [2]. Brokerage Recommendations - The current ABR of 1.88 is derived from four Strong Buy and one Buy recommendations, which account for 50% and 12.5% of all recommendations respectively [2]. - Despite the positive ABR, reliance solely on brokerage recommendations for investment decisions may not be prudent, as studies indicate limited success in guiding investors towards stocks with the best price increase potential [5]. Analyst Bias and Reliability - Brokerage analysts often exhibit a strong positive bias in their ratings due to vested interests, with research showing that for every "Strong Sell" recommendation, there are five "Strong Buy" recommendations [6]. - This misalignment of interests suggests that brokerage recommendations may not provide reliable insights into future stock price movements [7]. Zacks Rank Comparison - Zacks Rank, a proprietary stock rating tool, categorizes stocks from 1 (Strong Buy) to 5 (Strong Sell) and is based on earnings estimate revisions, which have a strong correlation with near-term stock price movements [8][11]. - The Zacks Rank is more timely and reflects current business trends, unlike the ABR, which may not be up-to-date [12]. Current Earnings Estimates for Onto Innovation - The Zacks Consensus Estimate for Onto Innovation has declined by 3.4% over the past month to $5.14, indicating growing pessimism among analysts regarding the company's earnings prospects [13]. - This decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for Onto Innovation, suggesting caution despite the Buy-equivalent ABR [14].

Core Viewpoint - The Governor of the Bank of Japan, Kazuo Ueda, emphasizes the high uncertainty surrounding economic and price forecasts due to developments in trade conditions, indicating a cautious approach without preconceived notions [1] Group 1 - The Bank of Japan is currently facing significant uncertainty in its economic outlook, primarily influenced by trade dynamics [1] - Governor Ueda suggests that the central bank will refrain from making judgments based on biases regarding the realization of economic and price forecasts [1]

Contango ORE, Inc. (CTGO) closed the last trading session at $21.30, gaining 24.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $29.33 indicates a 37.7% upside potential.The average comprises three short-term price targets ranging from a low of $26.00 to a high of $32.00, with a standard deviation of $3.06. While the lowest estimate indicates an increase of 22.1% from the curren ...

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a significant stock price increase of 57.1% over the past four weeks, closing at $9.22, with analysts suggesting a potential upside of 105% based on a mean price target of $18.9 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $4.04, indicating variability among analysts [2]. - The lowest price target is $12.00, suggesting a 30.2% increase from the current price, while the highest target is $25.00, indicating a potential surge of 171.2% [2]. - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [11]. - Over the last 30 days, two earnings estimates for ORIC have been revised upward, leading to a 7.8% increase in the Zacks Consensus Estimate [12]. - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14].

Group 1 - The stock of Kemper (KMPR) closed at $63.29, showing a 1.3% gain over the past four weeks, with a mean price target of $82.2 indicating a potential upside of 29.9% [1] - The average price targets from analysts range from a low of $75.00 to a high of $90.00, with a standard deviation of $5.72, suggesting a variability in estimates; the lowest estimate indicates an 18.5% increase, while the highest points to a 42.2% upside [2] - Analysts show strong agreement on the company's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.2% over the past month, with one estimate going higher and no negative revisions [12] - Kemper currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, the implied direction of price movement appears to be a good guide [14]

Core Viewpoint - Qifu Technology, Inc. (QFIN) shows potential for upside with a mean price target of $54.8, indicating a 27.3% increase from the current price of $43.06 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $4.14, suggesting a consensus among analysts [2] - The lowest estimate is $50.00, indicating a 16.1% increase, while the highest estimate is $58.50, suggesting a 35.9% increase [2] - Analysts' price targets should be approached with caution, as their reliability has been questioned [3][7] Earnings Estimates and Analyst Agreement - Strong agreement among analysts regarding QFIN's earnings prospects supports the potential for stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.3% over the past month, with two estimates revised upward [12] - QFIN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Teradyne (TER), and highlights the potential misalignment of interests between brokerage analysts and retail investors [1][5][10]. Group 1: Brokerage Recommendations for Teradyne - Teradyne has an average brokerage recommendation (ABR) of 1.93, indicating a consensus between Strong Buy and Buy, with 60% of recommendations being Strong Buy and 6.7% being Buy [2][4]. - The article suggests that relying solely on the ABR for investment decisions may not be advisable, as studies indicate that brokerage recommendations often fail to guide investors effectively [5][10]. Group 2: Limitations of Brokerage Recommendations - Brokerage analysts tend to exhibit a strong positive bias in their ratings due to vested interests, resulting in a disproportionate number of favorable ratings compared to negative ones [6][10]. - The article emphasizes that the best use of brokerage recommendations is to validate independent research rather than as a primary decision-making tool [7][10]. Group 3: Zacks Rank vs. ABR - Zacks Rank is presented as a more reliable tool for predicting stock performance, based on earnings estimate revisions, and is categorized into five groups from Strong Buy to Strong Sell [8][11]. - Unlike ABR, which may not be up-to-date, Zacks Rank reflects timely changes in earnings estimates, making it a more effective indicator for future stock prices [12]. Group 4: Current Earnings Estimates for Teradyne - The Zacks Consensus Estimate for Teradyne remains unchanged at $3.16 for the current year, suggesting stable analyst views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Teradyne holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].

Core Viewpoint - Analysts expect General Mills to report quarterly earnings of $0.71 per share, reflecting a year-over-year decline of 29.7%, with revenues projected at $4.6 billion, down 2.4% from the previous year [1] Earnings Estimates - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding stocks, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [2] Key Metrics Forecast - Analysts estimate 'Net Sales- North America Foodservice' at $593.35 million, indicating a year-over-year change of +0.7% [4] - 'Net Sales- International' is expected to reach $671.56 million, reflecting a +0.6% change from the year-ago quarter [4] - 'Net Sales- North America Pet' is projected at $646.14 million, showing a year-over-year increase of +7.3% [4] - 'Net Sales- North America Retail' is anticipated to be $2.71 billion, indicating a -5% change from the prior-year quarter [5] Operating Profit Estimates - 'Operating Profit- North America Retail' is expected to be $492.98 million, down from $670.10 million year-over-year [5] - 'Operating Profit- International' is projected at $32.83 million, compared to $22.40 million from the previous year [6] - 'Operating Profit- North America Pet' is estimated at $124.25 million, down from $143.90 million year-over-year [6] - 'Operating Profit- North America Foodservice' is expected to be $78.51 million, slightly down from $79.20 million year-ago [6] Stock Performance - Over the past month, General Mills shares have returned -0.8%, while the Zacks S&P 500 composite has changed by +0.6% [7] - General Mills currently holds a Zacks Rank 4 (Sell), indicating potential underperformance compared to the overall market in the near future [7]

Core Insights - Paychex (PAYX) is expected to report quarterly earnings of $1.19 per share, reflecting a 6.3% increase year over year, with revenues projected at $1.39 billion, a 7.3% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised down by 1.8% in the last 30 days, indicating a reassessment by analysts [2] - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between these revisions and short-term stock price performance [3] Revenue Projections - Analysts estimate 'Revenue- Management Solutions' at $1.01 billion, a 9% increase from the prior year [5] - 'Revenue- Interest on funds held for clients' is projected to reach $40.14 million, up 5.1% year over year [5] - 'Revenue- Total service revenue' is expected to be $1.36 billion, reflecting a 7.9% increase from the previous year [5] - 'Revenue- PEO and Insurance Services' is forecasted to be $341.79 million, a 4.7% increase year over year [6] Investment Balances - The 'Average investment Balance - Funds held for clients' is projected at $4.43 billion, down from $4.68 billion reported in the same quarter last year [6] - 'Average investment Balance - Corporate cash equivalents and investments' is expected to be $1.63 billion, compared to $1.65 billion a year ago [7] Interest Rates - Analysts expect 'Average interest rates earned - Funds held for clients' to be 3.4%, down from 3.5% in the same quarter last year [7] - 'Average interest rates earned - Corporate cash equivalents and investments' is projected to be 4.3%, compared to 5.3% a year ago [8] Stock Performance - Over the past month, Paychex shares have declined by 3.8%, while the Zacks S&P 500 composite has increased by 0.6% [9] - Paychex holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the near term [9]